List of Excipients in API dasatinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dasatinib
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
ER Squibb & Sons LLC | SPRYCEL | dasatinib | 0003-0527 | CELLULOSE, MICROCRYSTALLINE | |
ER Squibb & Sons LLC | SPRYCEL | dasatinib | 0003-0527 | CROSCARMELLOSE SODIUM | |
ER Squibb & Sons LLC | SPRYCEL | dasatinib | 0003-0527 | HYDROXYPROPYL CELLULOSE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dasatinib
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Apotex Corp | dasatinib | 60505-3628 | CELLULOSE, MICROCRYSTALLINE |
Apotex Corp | dasatinib | 60505-3628 | CROSCARMELLOSE SODIUM |
Apotex Corp | dasatinib | 60505-3628 | HYDROXYPROPYL CELLULOSE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for dasatinib
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
dasatinib drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dasatinib drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
dasatinib drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
dasatinib drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
dasatinib drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Apotex Corp | dasatinib | 60505-3628 |
Apotex Corp | dasatinib | 60505-3816 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | dasatinib | 54868-5759 |
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
dasatinib drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | dasatinib | 54868-5759 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Apotex Corp | dasatinib | 60505-3628 |
Apotex Corp | dasatinib | 60505-3816 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
dasatinib drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
dasatinib drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
dasatinib drug variants containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
dasatinib drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
Apotex Corp | dasatinib | 60505-3816 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
dasatinib drug variants containing POLYETHYLENE GLYCOLS
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | dasatinib | 54868-5759 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing POLYETHYLENE GLYCOLS
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Apotex Corp | dasatinib | 60505-3628 |
Apotex Corp | dasatinib | 60505-3816 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYL GALLATE
dasatinib drug variants containing PROPYL GALLATE
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing PROPYL GALLATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICA DIMETHYL SILYLATE
dasatinib drug variants containing SILICA DIMETHYL SILYLATE
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing SILICA DIMETHYL SILYLATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
dasatinib drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | dasatinib | 60505-3628 |
Apotex Corp | dasatinib | 60505-3816 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dasatinib drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Apotex Corp | dasatinib | 60505-3628 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
dasatinib drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Apotex Corp | dasatinib | 60505-3628 |
Apotex Corp | dasatinib | 60505-3816 |
>Company | >Ingredient | >NDC |
dasatinib drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
ER Squibb & Sons LLC | dasatinib | 0003-0527 |
Physicians Total Care Inc | dasatinib | 54868-5759 |
Nanocopoeia | dasatinib | 83858-101 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.